SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) April 30, 2002
---------------------
MATRIA HEALTHCARE, INC.
----------------------------------------------------------------------------
(Exact name of registrant as specified in its charter)
Delaware 0-20619 58-2205984
-----------------------------------------------------------------------------
State or other (Commission (IRS Employer
jurisdiction of File Number) Identification No.)
incorporation)
1850 Parkway Place, Marietta, GA 30067
-----------------------------------------------------------------------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code (770) 423-4500
-------------------
Not Applicable
-----------------------------------------------------------------------------
(Former name or former address, if changed since last report)
Item 7. Financial Statements, Pro Forma Financial Information and Exhibits.
-------------------------------------------------------------------
(c) Exhibits.
99 April 30, 2002 Investor Conference Presentation
Item 9. Regulation FD Disclosure.
------------------------
On April 30, 2002, at 2:00 p.m. Matria Healthcare, Inc. will
conduct a conference call to discuss the acquisition of Quality
Oncology. A presentation of items to be discussed on the call is furnished
herewith as Exhibit 99. All information in the presentation is presented as
of April 30, 2002 and Matria Healthcare, Inc. does not assume any obligation
to update said information in the future.
This presentation contains forward-looking statements. All
forward-looking statements are based on then current expectations and involve a
number of risks and uncertainties which are discussed in detail in our
Securities and Exchange Commission filings, including our Annual report on Form
10-K for the year ended December 31, 2001. By making these forward-looking
statements, Matria does not undertake to update them in any manner except as may
be required by Matria's disclosure obligations in filings it makes with the
Securities and Exchange Commission under the federal securities laws.
The information set forth under this Item 9 and Exhibit 99.1 is being
furnished for informational purposes only pursuant to Regulation FD and is not
filed pursuant to the Securities Exchange Act of 1934, as amended. None of this
information may be incorporated by reference into any other filings Matria has
made or may make pursuant to the Securities Act of 1933, as amended or into any
other documents unless such portion of this Current Report on Form 8-K is
expressly and specifically identified in such filling as being incorporated by
reference therein.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
Matria has duly caused this Report to be signed on its behalf by the undersigned
hereunto duly authorized.
Matria Healthcare, Inc.
Registrant
By: /s/ Parker H. Petit
Parker H. Petit
Chairman of the Board, President and
Chief Executive Officer
Date: April 30, 2002